Chemoswed

Chemoswed is a Swedish contract development and manufacturing organization (CDMO) specializing in the development and production of active pharmaceutical ingredients (APIs) and advanced intermediates. Based in Malmö, the company provides services ranging from initial process research and development to full-scale commercial manufacturing under GMP conditions. Chemoswed focuses primarily on small molecule chemistry, offering expertise in complex synthesis and hazardous chemistry. Since its acquisition, it has operated as a key manufacturing site within the Seqens group, serving global pharmaceutical and biotech clients. The facility is equipped to handle projects from early clinical phases through to commercial supply, supported by robust analytical and regulatory services.